Dividend
-
-
-
-
-
-
-
Xtant Medical Reports Third Quarter 2017 Financial Results
-
-
-
-
-
-
-
Xtant Medical Reports Second Quarter 2017 Financial Results
-
-
-
-
-
-
-
Xtant Medical Enters into Licensing Agreement for Sites Medical’s OsteoSync Ti Technology
-
-
-
-
-
-
-
Xtantâ„¢ Medical Receives Going Concern Opinion
-
-
-
-
-
-
-
XTNT Announces Closing of Registered Direct Offering
-
-
-
-
-
-
-
Xtant Medical Announces Expiration of Rights Offering and Estimated Gross Proceeds of $3.8 Million
-
-
-
-
-
-
-
Xtant Medical Receives Approval of Compliance Plan from NYSE MKT
-
436,668 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All

